Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-28 @ 8:24 PM
Study NCT ID:
NCT07072234
Status:
RECRUITING
Last Update Posted:
2025-10-07
First Post:
2025-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-09
First Submit QC Date:
None
Study First Post Date:
2025-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-01
Last Update Post Date:
2025-10-07
Last Update Post Date Type:
ESTIMATED